WebMar 22, 2024 · Statin therapy is widely used for both the secondary and primary prevention of atherosclerotic cardiovascular disease. However, the randomized trials that have provided evidence of benefit have included few patients with heart failure (HF) [ 1,2 ]. Web1 day ago · Effectiveness of LDL-C–lowering therapy is most efficiently reached in patients with high baseline cholesterol and high cardiovascular risk. ... No dose adjustment of statin therapy is required for CKD stage 3, whereas only moderate statin doses should be prescribed in CKD stage 4/5. ... or lung ultrasound. Patients with CKD are less likely ...

Management of Hypertriglyceridemia AAFP

Webculate the 10-year risk. Rather, high-intensity statin therapy should be started right away to lower LDL-C by at least 50%. If the LDL-C level remains higher than 100 mg/dL with maximal tolerated statin therapy, ezetimibe can be added (class IIb rec-ommendation, ie, weak recommendation, but benefi t exceeds risk). little britches rodeo south dakota

Hyperlipidemia Pediatrics In Review - American Academy of …

WebStatin therapy is first-line treatment for primary prevention of ASCVD in patients with elevated low-density lipoprotein cholesterol levels (≥190 mg/dL), those with diabetes mellitus, who are 40 to 75 years of age, and those determined to be at sufficient ASCVD risk after a clinician–patient risk discussion. WebSep 1, 2011 · In an acute setting, initiating statin therapy may reduce stroke severity and disability, with data supporting 40 to 80 mg of atorvastatin daily over 20 to 80 mg of simvastatin daily. 48... WebJul 27, 2015 · Among the recommendations was that people 40 to 75 years of age without clinical ASCVD and diabetes should take statins if they have an LDL cholesterol level of 70 to 189 mg/dL and an estimated 10-year ASCVD risk of 7.5% or more. The guidelines also included methods for making this risk estimate. little britain yes gif